A new study led by BC Cancer researchers shows that classic Hodgkin lymphoma (CHL) is not one disease, but several biologically distinct subtypes. The study, published in Cancer Discovery, a journal of the American Association for Cancer Research, shows each disease subtype is caused by different genetic changes and interacts uniquely with the immune system.
The seed2STEM Summer Research Program for Indigenous Youth increases Indigenous representation in science, technology, engineering and mathematics (STEM) by offering paid, six-week research studentships for Indigenous high school and university students across BC. Developed by ICORD, the program expanded this past summer to BC Cancer in partnership with the Gynecologic Cancer Initiative.
Building a new chapter
Dr. Christian Steidl, senior scientist and Executive Director, Research at BC Cancer, is the recipient of a 2025 Operating Grant in Blood Cancer, co-funded by AstraZeneca Canada and the Leukemia & Lymphoma Society of Canada.
The research is dedicated to developing innovative tools for precise and efficient gene editing in B-cell lymphomas. By targeting the underlying genetic causes of cancer, this work paves the way for novel treatment strategies and opens new possibilities for patients living with B-cell lymphoma.
Congratulations to the recipients of the BC Cancer Foundation (BCCF) Rising Stars Graduate Awards competition!
This year’s awardees are:
Congratulations to the recipients of the BC Cancer Foundation (BCCF) 2024 Rising Stars Award competition!
This year’s awardees are:
Dr. Ryan Morin (Centre for Lymphoid Cancer) is the co-recipient of the Canadian Cancer Society (CCS) Bernard and Francine Dorval Prize.
Dr. Morin is a national and international leader in his field of studying how changes to our genes lead to cancer. He has conducted cutting-edge research that has directly helped doctors understand, diagnose and better treat lymphomas.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.